Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Apr 1;183(4):1331–1338. doi: 10.1084/jem.183.4.1331

Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L

PMCID: PMC2192513  PMID: 8666891

Abstract

The invariant chain (Ii) is associated with major histocompatibility complex class II molecules during early stages of their intracellular transport. In an acidic endosomal/lysosomal compartment, it is proteolytically cleaved and removed from class II heterodimers. Participation of aspartic and cysteine proteases has been observed in in vitro degradation of Ii, but the specific enzymes responsible for its in vivo processing are as yet undefined. We have previously isolated a noncovalent complex of the lysosomal cysteine protease cathepsin L with a peptide fragment derived from the p41 form of Ii from human kidney. Here we show that this Ii fragment, which is identical to the alternatively spliced segment of p41, is a very potent competitive inhibitor of cathepsin L (equilibrium inhibition constant Ki = 1.7 X 10(-12) M). It inhibits two other cysteine proteases, cathepsin H and papain, but to much lesser extent. Cysteine proteases cathepsins B, C, and S, as well as representatives of serine, aspartic, and metalloproteases, are not inhibited at all. These findings suggest a novel role for p41 in the regulation of various proteolytic activities during antigen processing and presentation. The Ii inhibitory fragment shows no sequence homology with the known cysteine protease inhibitors, and may, therefore, represent a new class.

Full Text

The Full Text of this article is available as a PDF (873.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adorini L., Muller S., Cardinaux F., Lehmann P. V., Falcioni F., Nagy Z. A. In vivo competition between self peptides and foreign antigens in T-cell activation. Nature. 1988 Aug 18;334(6183):623–625. doi: 10.1038/334623a0. [DOI] [PubMed] [Google Scholar]
  2. Anderson M. S., Miller J. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2282–2286. doi: 10.1073/pnas.89.6.2282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson M. S., Swier K., Arneson L., Miller J. Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J Exp Med. 1993 Dec 1;178(6):1959–1969. doi: 10.1084/jem.178.6.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arunachalam B., Lamb C. A., Cresswell P. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int Immunol. 1994 Mar;6(3):439–451. doi: 10.1093/intimm/6.3.439. [DOI] [PubMed] [Google Scholar]
  5. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 1990 Nov 16;63(4):707–716. doi: 10.1016/0092-8674(90)90137-4. [DOI] [PubMed] [Google Scholar]
  6. Blum J. S., Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3975–3979. doi: 10.1073/pnas.85.11.3975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dolenc I., Turk B., Pungercic G., Ritonja A., Turk V. Oligomeric structure and substrate induced inhibition of human cathepsin C. J Biol Chem. 1995 Sep 15;270(37):21626–21631. doi: 10.1074/jbc.270.37.21626. [DOI] [PubMed] [Google Scholar]
  8. Freisewinkel I. M., Schenck K., Koch N. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9703–9706. doi: 10.1073/pnas.90.20.9703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 1993;11:403–450. doi: 10.1146/annurev.iy.11.040193.002155. [DOI] [PubMed] [Google Scholar]
  10. Gorvel J. P., Escola J. M., Stang E., Bakke O. Invariant chain induces a delayed transport from early to late endosomes. J Biol Chem. 1995 Feb 10;270(6):2741–2746. doi: 10.1074/jbc.270.6.2741. [DOI] [PubMed] [Google Scholar]
  11. Guagliardi L. E., Koppelman B., Blum J. S., Marks M. S., Cresswell P., Brodsky F. M. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature. 1990 Jan 11;343(6254):133–139. doi: 10.1038/343133a0. [DOI] [PubMed] [Google Scholar]
  12. Jones P. P., Murphy D. B., Hewgill D., McDevitt H. O. Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates. Mol Immunol. 1979 Jan;16(1):51–60. doi: 10.1016/0161-5890(79)90027-0. [DOI] [PubMed] [Google Scholar]
  13. Katunuma N., Kakegawa H., Matsunaga Y., Saibara T. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family. FEBS Lett. 1994 Aug 1;349(2):265–269. doi: 10.1016/0014-5793(94)00657-1. [DOI] [PubMed] [Google Scholar]
  14. Kämpgen E., Koch N., Koch F., Stöger P., Heufler C., Schuler G., Romani N. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3014–3018. doi: 10.1073/pnas.88.8.3014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ludwig T., Griffiths G., Hoflack B. Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells. J Cell Biol. 1991 Dec;115(6):1561–1572. doi: 10.1083/jcb.115.6.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Malthiéry Y., Lissitzky S. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem. 1987 Jun 15;165(3):491–498. doi: 10.1111/j.1432-1033.1987.tb11466.x. [DOI] [PubMed] [Google Scholar]
  17. Marić M. A., Taylor M. D., Blum J. S. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2171–2175. doi: 10.1073/pnas.91.6.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Matsunaga Y., Saibara T., Kido H., Katunuma N. Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett. 1993 Jun 21;324(3):325–330. doi: 10.1016/0014-5793(93)80144-j. [DOI] [PubMed] [Google Scholar]
  19. Morabito M. A., Moczydlowski E. Molecular cloning of bullfrog saxiphilin: a unique relative of the transferrin family that binds saxitoxin. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2478–2482. doi: 10.1073/pnas.91.7.2478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Morrison J. F., Walsh C. T. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol. 1988;61:201–301. doi: 10.1002/9780470123072.ch5. [DOI] [PubMed] [Google Scholar]
  21. Morton P. A., Zacheis M. L., Giacoletto K. S., Manning J. A., Schwartz B. D. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J Immunol. 1995 Jan 1;154(1):137–150. [PubMed] [Google Scholar]
  22. Muno D., Sutoh N., Watanabe T., Uchiyama Y., Kominami E. Effect of metabolic alterations on the density and the contents of cathepsins B, H and L of lysosomes in rat macrophages. Eur J Biochem. 1990 Jul 20;191(1):91–98. doi: 10.1111/j.1432-1033.1990.tb19097.x. [DOI] [PubMed] [Google Scholar]
  23. Nakae H., Sugano M., Ishimori Y., Endo T., Obinata T. Ascidian entactin/nidogen. Implication of evolution by shuffling two kinds of cysteine-rich motifs. Eur J Biochem. 1993 Apr 1;213(1):11–19. doi: 10.1111/j.1432-1033.1993.tb17729.x. [DOI] [PubMed] [Google Scholar]
  24. Naujokas M. F., Morin M., Anderson M. S., Peterson M., Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 1993 Jul 30;74(2):257–268. doi: 10.1016/0092-8674(93)90417-o. [DOI] [PubMed] [Google Scholar]
  25. Neefjes J. J., Stollorz V., Peters P. J., Geuze H. J., Ploegh H. L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 1990 Apr 6;61(1):171–183. doi: 10.1016/0092-8674(90)90224-3. [DOI] [PubMed] [Google Scholar]
  26. Odorizzi C. G., Trowbridge I. S., Xue L., Hopkins C. R., Davis C. D., Collawn J. F. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol. 1994 Jul;126(2):317–330. doi: 10.1083/jcb.126.2.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ogrinc T., Dolenc I., Ritonja A., Turk V. Purification of the complex of cathepsin L and the MHC class II-associated invariant chain fragment from human kidney. FEBS Lett. 1993 Dec 28;336(3):555–559. doi: 10.1016/0014-5793(93)80875-u. [DOI] [PubMed] [Google Scholar]
  28. Ojcius D. M., Gapin L., Kanellopoulos J. M., Kourilsky P. Is antigen processing guided by major histocompatibility complex molecules? FASEB J. 1994 Sep;8(12):974–978. doi: 10.1096/fasebj.8.12.8088463. [DOI] [PubMed] [Google Scholar]
  29. Peters P. J., Neefjes J. J., Oorschot V., Ploegh H. L., Geuze H. J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature. 1991 Feb 21;349(6311):669–676. doi: 10.1038/349669a0. [DOI] [PubMed] [Google Scholar]
  30. Peterson M., Miller J. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature. 1992 Jun 18;357(6379):596–598. doi: 10.1038/357596a0. [DOI] [PubMed] [Google Scholar]
  31. Peterson M., Miller J. Invariant chain influences the immunological recognition of MHC class II molecules. Nature. 1990 May 10;345(6271):172–174. doi: 10.1038/345172a0. [DOI] [PubMed] [Google Scholar]
  32. Pieters J., Horstmann H., Bakke O., Griffiths G., Lipp J. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J Cell Biol. 1991 Dec;115(5):1213–1223. doi: 10.1083/jcb.115.5.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Reyes V. E., Lu S., Humphreys R. E. Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains. J Immunol. 1991 Jun 1;146(11):3877–3880. [PubMed] [Google Scholar]
  34. Roche P. A., Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature. 1990 Jun 14;345(6276):615–618. doi: 10.1038/345615a0. [DOI] [PubMed] [Google Scholar]
  35. Roche P. A., Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3150–3154. doi: 10.1073/pnas.88.8.3150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rodriguez G. M., Diment S. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin. Eur J Immunol. 1995 Jul;25(7):1823–1827. doi: 10.1002/eji.1830250705. [DOI] [PubMed] [Google Scholar]
  37. Romagnoli P., Layet C., Yewdell J., Bakke O., Germain R. N. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med. 1993 Mar 1;177(3):583–596. doi: 10.1084/jem.177.3.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Smith R., Turk V. Cathepsin D: rapid isolation by affinity chromatography on haemoglobin-agarose resin. Eur J Biochem. 1974 Oct 1;48(1):245–254. doi: 10.1111/j.1432-1033.1974.tb03762.x. [DOI] [PubMed] [Google Scholar]
  39. Strubin M., Berte C., Mach B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J. 1986 Dec 20;5(13):3483–3488. doi: 10.1002/j.1460-2075.1986.tb04673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tulp A., Verwoerd D., Dobberstein B., Ploegh H. L., Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature. 1994 May 12;369(6476):120–126. doi: 10.1038/369120a0. [DOI] [PubMed] [Google Scholar]
  41. Turk B., Dolenc I., Turk V., Bieth J. G. Kinetics of the pH-induced inactivation of human cathepsin L. Biochemistry. 1993 Jan 12;32(1):375–380. doi: 10.1021/bi00052a046. [DOI] [PubMed] [Google Scholar]
  42. Turk V., Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991 Jul 22;285(2):213–219. doi: 10.1016/0014-5793(91)80804-c. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES